PLEKHG4 and thyroid gland carcinoma: The authors further examined the effects of PLEKHG4 on cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) by overexpressing or knocking down PLEKHG4 in thyroid cancer cells.